SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature.
Saved in:
| Title: | SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature. |
|---|---|
| Authors: | Fignani D; Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy., Licata G; Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy., Brusco N; Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy., Nigi L; Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy., Grieco GE; Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy., Marselli L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Overbergh L; Clinical and Experimental Endocrinology (CEE), Katholieke Universiteit Leuven (KULEUVEN), Leuven, Belgium., Gysemans C; Clinical and Experimental Endocrinology (CEE), Katholieke Universiteit Leuven (KULEUVEN), Leuven, Belgium., Colli ML; ULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, Brussels, Belgium., Marchetti P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Mathieu C; Clinical and Experimental Endocrinology (CEE), Katholieke Universiteit Leuven (KULEUVEN), Leuven, Belgium., Eizirik DL; ULB Center for Diabetes Research, Medical Faculty, Université Libre de Bruxelles, Brussels, Belgium.; Indiana Biosciences Research Institute, Indianapolis, IN, United States., Sebastiani G; Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy., Dotta F; Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario, c/o Toscana Life Sciences, Siena, Italy.; Tuscany Centre for Precision Medicine (CReMeP), Siena, Italy. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2020 Nov 13; Vol. 11, pp. 596898. Date of Electronic Publication: 2020 Nov 13 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2020.596898 |
